Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vermeulen

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
EMBO Molecular Medicine|November 9, 2023
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencingYmke van der Pol, Normastuti Adhini Tantyo, Nils Evander, et al.
The Journal of Pathology. Clinical Research|May 14, 2020
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancerAntonia K Roseweir, James H Park, Sanne Ten Hoorn, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Cell Stem Cell|August 6, 2021
Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreasSophie C Lodestijn, Tom van den Bosch, Lisanne E Nijman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2023
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancerJoyce Y Buikhuisen, Patricia M Gomez Barila, Kate Cameron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2025
High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancerXionge Mei, Seth-Frerich Fobian, Marloes IJff, et al.
Cancers|June 2, 2021
Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and ExpressionJanneke F Linnekamp, Raju Kandimalla, Evelyn Fessler, et al.
Cell Stem Cell|November 8, 2011
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patientsFelipe de Sousa E Melo, Selcuk Colak, Joyce Buikhuisen, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
EMBO Molecular Medicine|November 9, 2023
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencingYmke van der Pol, Normastuti Adhini Tantyo, Nils Evander, et al.
The Journal of Pathology. Clinical Research|May 14, 2020
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancerAntonia K Roseweir, James H Park, Sanne Ten Hoorn, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Cell Stem Cell|August 6, 2021
Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreasSophie C Lodestijn, Tom van den Bosch, Lisanne E Nijman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2023
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancerJoyce Y Buikhuisen, Patricia M Gomez Barila, Kate Cameron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2025
High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancerXionge Mei, Seth-Frerich Fobian, Marloes IJff, et al.
Cancers|June 2, 2021
Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and ExpressionJanneke F Linnekamp, Raju Kandimalla, Evelyn Fessler, et al.
Cell Stem Cell|November 8, 2011
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patientsFelipe de Sousa E Melo, Selcuk Colak, Joyce Buikhuisen, et al.
Pageof 16